SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-009874
Filing Date
2024-02-01
Accepted
2024-02-01 17:27:41
Documents
16
Period of Report
2024-01-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crbp-20240130.htm   iXBRL 8-K 52819
2 EX-1.1 crbp-ex1_1.htm EX-1.1 383530
3 EX-5.1 crbp-ex5_1.htm EX-5.1 19139
4 EX-99.1 crbp-ex99_1.htm EX-99.1 12022
5 EX-99.2 crbp-ex99_2.htm EX-99.2 11326
  Complete submission text file 0000950170-24-009874.txt   668887

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT crbp-20240130.xsd EX-101.SCH 25032
18 EXTRACTED XBRL INSTANCE DOCUMENT crbp-20240130_htm.xml XML 4767
Mailing Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001595097 (see all company filings)

IRS No.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37348 | Film No.: 24588016
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)